packageAbemaciclib

abemaciclib

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Abemaciclib is a CDK inhibitor used to treat breast cancer. It is an approved medicine and is authorised in the European Union for breast cancer.

Summary written by glm-5.3-flash from Wikidata Q23901483 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:abemaciclib
ATC codes:L01EF03
DrugBank:DB12001
PubChem CID:46220502
Wikidata:Q23901483
formula:C27H32F2N8
molar mass:506.605 g/mol (PubChem CID 46220502)
logP:3.8 (Drugs.Common 25.09, not verified)

Metabolites

M2LSN2839567M2 (LSN2839567)molar mass unknown
M20LSN3106726M20 (LSN3106726)molar mass unknown

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown

Contents

NameDescription
M2LSN2839567metabolite: M2 (LSN2839567)
M20LSN3106726metabolite: M20 (LSN3106726)